Maximum quantity allowed is 999
CAS RN: 64461-82-1 | Product Number: T2527
Tizanidine Hydrochloride
 
									 
							Purity: >98.0%(T)(HPLC)
- 5-Chloro-4-[(4,5-dihydro-1H-imidazol-2-yl)amino]-2,1,3-benzothiadiazole Hydrochloride
| Size | Unit Price | Hyderabad | Japan* | Quantity | 
|---|---|---|---|---|
| 5G | 
                                                ₹5,200.00 | 1 | 35 |  | 
| 25G | 
                                                ₹8,600.00 | 2 | ≥40 |  | 
						*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
						*Items available in Japan warehouse will be dispatched in 10-12 working days.
						*INR price is exclusive of domestic taxes applicable.
						*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | T2527 | 
| Purity / Analysis Method   | >98.0%(T)(HPLC) | 
| Molecular Formula / Molecular Weight | C__9H__8ClN__5S·HCl = 290.17 | 
| Physical State (20 deg.C) | Solid | 
| Storage Temperature   | Room Temperature (Recommended in a cool and dark place, <15°C) | 
| CAS RN | 64461-82-1 | 
| Related CAS RN   | 51322-75-9 | 
| Reaxys Registry Number | 6022764 | 
| PubChem Substance ID | 87560328 | 
| Merck Index (14) | 9485 | 
| MDL Number | MFCD00798231 | 
| Appearance | White to Yellow to Orange powder to crystal | 
| Purity(HPLC) | min. 98.0 area% | 
| Purity(Nonaqueous Titration) | min. 98.0 % | 
| Melting Point | 280 °C | 
| Solubility in water | Soluble | 
| Pictogram |   | 
| Signal Word | Warning | 
| Hazard Statements | H302 : Harmful if swallowed. H315 : Causes skin irritation. H319 : Causes serious eye irritation. | 
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. | 
| RTECS# | DK9910000 | 
References
- Tizanidine: a review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders
- Tizanidine is mainly metabolized by cytochrome P450 1A2 in vitro
- Formulation, evaluation and optimization of fast dissolving tablet containing Tizanidine Hydrochloride
- Application of HPLC and HPTLC for the simultaneous determination of tizanidine and rofecoxib in pharmaceutical dosage form
- Simultaneous RP-HPLC estimation of tizanidine, diclofenac potassium, and paracetamol in tablets
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
					 
			  
		  
                                			The requested analytical chart is not available. Sorry for the inconvenience.

 
       
	